These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7283815)

  • 1. Ac2IDU, BVDU, and thymine arabinoside therapy in experimental herpes keratitis.
    Hettinger ME; Pavan-Langston D; Park NH; Albert DM; De Clercq E; Lin TS
    Arch Ophthalmol; 1981 Sep; 99(9):1618-21. PubMed ID: 7283815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. (E)-5-(2-bromovinyl)-2'-Deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; De Somer P; Busson R; Vanderhaeghe H; Verhelst G; Walker RT; Jones AS
    Antimicrob Agents Chemother; 1980 Jan; 17(1):8-12. PubMed ID: 7352751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Experimental thymidine kinase-deficient HSV-1 keratitis: therapeutic attempts.
    Maudgal PC; De Clercq E; Huyghe P
    Curr Eye Res; 1987 Apr; 6(4):579-84. PubMed ID: 2953558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of BVDU ((E)-5-(2-bromovinyl)-2'-deoxyuridine) in the treatment of experimental herpes simplex keratitis in rabbits.
    Maudgal PC; De Clercq E; Descamps J; Missotten L
    Bull Soc Belge Ophtalmol; 1979; 186():109-18. PubMed ID: 554711
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental stroma herpes simplex keratitis. Influence of treatment with topical bromovinyldeoxyuridine and trifluridine.
    Maudgal PC; De Clercq E; Descamps J; Missotten L; Wijnhoven J
    Arch Ophthalmol; 1982 Apr; 100(4):653-6. PubMed ID: 6803747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of bromovinyldeoxyuridine in the treatment of herpes simplex virus and varicella-zoster virus eye infections.
    Maudgal PC; De Clercq E; Missotten L
    Antiviral Res; 1984 Oct; 4(5):281-91. PubMed ID: 6335020
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of (E)-5-(2-bromovinyl)-2'-deoxyuridine in the topical treatment of herpes simplex keratitis.
    Maudgal PC; Missotten L; De Clercq E; Descamps J; De Meuter E
    Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1981; 216(4):261-8. PubMed ID: 7020469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of (E)-5-(2-bromovinyl)- and 5-vinyl-1-beta-D-arabinofuranosyluracil (BrVaraU, VaraU) in the treatment of experimental herpes simplex virus type 1 keratitis in rabbits: comparison with (E)-5-(2-bromovinyl)-2'-deoxyuridine (BrVUdR).
    Töpke H; Gräf M; Wutzler P; Herrmann G; Reefschläger J
    Antiviral Res; 1988 Jul; 9(4):273-80. PubMed ID: 3202622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of 9-(2-phosphonylmethoxyethyl)adenine in the therapy of TK+ and TK- herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():139-42. PubMed ID: 1650660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (S)-1-(3-hydroxy-2-phosphonyl-methoxypropyl)cytosine in the therapy of thymidine kinase-positive and -deficient herpes simplex virus experimental keratitis.
    Maudgal PC; De Clercq E
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1816-20. PubMed ID: 1851733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative efficacy of 5-methoxymethyl-2'-deoxyuridine, 9 beta-D-arabinofuranosyladenine and 5-iodo-2'-deoxyuridine in the treatment of experimental herpes simplex keratitis.
    Meldrum JB; Gupta VS; Babiuk LA
    Chemotherapy; 1980; 26(1):54-63. PubMed ID: 7353440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acyclic antimetabolite therapy of experimental herpes simplex keratitis.
    Pavan-Langston D; Campbell R; Lass J
    Am J Ophthalmol; 1978 Nov; 86(5):618-23. PubMed ID: 213976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of bromovinyldeoxyuridine-related compounds in the treatment of experimental herpes simplex keratitis.
    Maudgal PC; De Clercq E
    Arch Ophthalmol; 1985 Sep; 103(9):1393-7. PubMed ID: 4038133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chemotherapy of herpetic infections].
    Barinskiĭ IF; L'vov ND; Samoĭlovich EO
    Vopr Virusol; 1986; 31(1):6-18. PubMed ID: 3515765
    [No Abstract]   [Full Text] [Related]  

  • 15. Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes.
    Trousdale MD; Nesburn AB; Su TL; Lopez C; Watanabe KA; Fox JJ
    Antimicrob Agents Chemother; 1983 Jun; 23(6):808-13. PubMed ID: 6311085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
    Sundmacher R
    Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bromovinyldeoxyuridine treatment of herpetic keratitis clinically resistant to other antiviral agents.
    Maudgal PC; De Clercq E
    Curr Eye Res; 1991; 10 Suppl():193-9. PubMed ID: 1650667
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of (S)-HPMPA against thymidine kinase-deficient herpes simplex virus-keratitis.
    Maudgal PC; De Clercq E; Huyghe P
    Invest Ophthalmol Vis Sci; 1987 Feb; 28(2):243-8. PubMed ID: 8591903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intentional reactivation of latent ocular herpes infection during BVDU therapy.
    Trousdale MD; Robin JB; Willey DE; De Clercq E
    Curr Eye Res; 1987 Dec; 6(12):1471-7. PubMed ID: 2827960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Herpes simplex keratitis.
    Kaufman HE; Centifanto-Fitzgerald YM; Varnell ED
    Ophthalmology; 1983 Jun; 90(6):700-6. PubMed ID: 6310466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.